CTIS.eu › Drugs › Pneumococcal Polysaccharide Serotype 6A, Pneumococcal Polysaccharide Serotype 4, Pneumococcal Polysaccharide Serotype 6B, Pneumococcal Polysaccharide Serotype 9V, Pneumococcal Polysaccharide Serotype 14, Pneumococcal Polysaccharide Serotype 18C, Pneumococcal Polysaccharide Serotype 19F, Pneumococcal Polysaccharide Serotype 23F, Pneumococcal Polysaccharide Serotype 33F, Pneumococcal Polysaccharide Serotype 8, Pneumococcal Polysaccharide Serotype 22F, Pneumococcal Polysaccharide Serotype 19A, Pneumococcal Polysaccharide Serotype 15B, Pneumococcal Polysaccharide Serotype 12F, Pneumococcal Polysaccharide Serotype 11A, Pneumococcal Polysaccharide Serotype 9N, Pneumococcal Polysaccharide Serotype 7F, Pneumococcal Polysaccharide Serotype 5, Pneumococcal Polysaccharide Serotype 3, Pneumococcal Polysaccharide Serotype 1, Pneumococcal Polysaccharide Serotype 10A

Pneumococcal Polysaccharide Serotype 6A, Pneumococcal Polysaccharide Serotype 4, Pneumococcal Polysaccharide Serotype 6B, Pneumococcal Polysaccharide Serotype 9V, Pneumococcal Polysaccharide Serotype 14, Pneumococcal Polysaccharide Serotype 18C, Pneumococcal Polysaccharide Serotype 19F, Pneumococcal Polysaccharide Serotype 23F, Pneumococcal Polysaccharide Serotype 33F, Pneumococcal Polysaccharide Serotype 8, Pneumococcal Polysaccharide Serotype 22F, Pneumococcal Polysaccharide Serotype 19A, Pneumococcal Polysaccharide Serotype 15B, Pneumococcal Polysaccharide Serotype 12F, Pneumococcal Polysaccharide Serotype 11A, Pneumococcal Polysaccharide Serotype 9N, Pneumococcal Polysaccharide Serotype 7F, Pneumococcal Polysaccharide Serotype 5, Pneumococcal Polysaccharide Serotype 3, Pneumococcal Polysaccharide Serotype 1, Pneumococcal Polysaccharide Serotype 10A

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

9 Countries

Phase III

Phase III: 2

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Pneumococcal immunisation 2

Sponsors using this IMP

Sanofi Pasteur 2

All trials

2 total

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from Approximately 2 Months of Age Recruiting

2023-507600-32-00 Phase III 9 countries Sanofi Pasteur Inc.
Study of the Safety and lmmunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, T… Ended

2024-512271-13-00 Phase III 2 countries Sanofi Pasteur Inc.

Showing 1–2 of 2 trials

← All drugs A–Z